Company Filing History:
1 out of 71 
1 out of 3,539 
1 out of 173 
Years Active: 2005
Title: Samar Hammad: Innovator in HDL Holoparticle Research
Introduction
Samar Hammad is a notable inventor based in Charleston, SC (US). She has made significant contributions to the field of biochemistry, particularly in the study of high-density lipoprotein (HDL) holoparticles. Her innovative work has led to the development of a patented method that has potential implications for health and disease management.
Latest Patents
Samar Hammad holds a patent for "Methods and compositions for HDL holoparticle uptake receptor." This invention provides an isolated mammalian receptor that specifically binds to a high-density lipoprotein holoparticle. The receptor comprises a subunit of approximately 45-600 kDa molecular weight and includes one or more subunits selected from a specific range of molecular weights. Additionally, the patent outlines a method for screening substances that can modulate the HDL holoparticle binding and internalization activity of the receptor.
Career Highlights
Throughout her career, Samar has worked with esteemed organizations such as the American National Red Cross and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these institutions has allowed her to contribute to important research initiatives and public health projects.
Collaborations
Samar has collaborated with notable colleagues, including William S. Argraves and Steingrimur P. Stefansson. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Samar Hammad's innovative research and patent in HDL holoparticle uptake receptors highlight her contributions to biochemistry and public health. Her work continues to inspire advancements in the understanding of lipid metabolism and its implications for health.